Click for best price
Recombinant Hepatitis B Vaccine Market Size, Share 2023
The hepatitis b vaccine is a vaccine against hepatitis b.That is, from hepatitis b virus carrier plasma isolation of hepatitis b surface antigen (HbsAg), after treatment and made.After second liver vaccine is inoculated, can stimulate immune system to produce protective antibody, this kind of antibody is in the humoral in the person, once second liver virus appears, antibody can act immediately, clear its, prevent infection, won't harm liver, make human body had the immunity that prevents second liver thereby.Therefore, hepatitis b vaccine has become an indispensable umbrella in life.Prevention generally lasts for at least 12 years, so there is no need for anti-hbs surveillance or enhanced immunity in the general population.However, anti-hbs surveillance can be carried out on high-risk groups, such as anti-hbs <10mIU/ml, which can be given enhanced immunity.
This report aims to provide a comprehensive presentation of the global market for Recombinant Hepatitis B Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Hepatitis B Vaccine. This report contains market size and forecasts of Recombinant Hepatitis B Vaccine in global, including the following market information:
Global Recombinant Hepatitis B Vaccine Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Recombinant Hepatitis B Vaccine Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Recombinant Hepatitis B Vaccine companies in 2022 (%)
The global Recombinant Hepatitis B Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
10mcg/ml Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant Hepatitis B Vaccine include Merck, GlaxoSmithKline Plc, Pfizer Inc., Sanofi Pasteur, CSL Limited, Emergent Biosolutions, Serum Institute of India, Johnson & Johnson and Hualan Biological Engineering, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Hepatitis B Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Hepatitis B Vaccine Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Recombinant Hepatitis B Vaccine Market Segment Percentages, by Type, 2022 (%)
10mcg/ml
10mcg/0.5ml
Global Recombinant Hepatitis B Vaccine Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Recombinant Hepatitis B Vaccine Market Segment Percentages, by Application, 2022 (%)
Newborn
Primary School Students
Adult
Global Recombinant Hepatitis B Vaccine Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Recombinant Hepatitis B Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Hepatitis B Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Hepatitis B Vaccine revenues share in global market, 2022 (%)
Key companies Recombinant Hepatitis B Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Recombinant Hepatitis B Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
GlaxoSmithKline Plc
Pfizer Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Serum Institute of India
Johnson & Johnson
Hualan Biological Engineering
NCPC
China National Biotec Group
Dalian Hissen Bio-pharm
Beijing Tiantan Biological
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Hepatitis B Vaccine, market overview.
Chapter 2: Global Recombinant Hepatitis B Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Hepatitis B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Hepatitis B Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Hepatitis B Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Recombinant Hepatitis B Vaccine Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
76 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Hepatitis B Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Hepatitis B Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Hepatitis B Vaccine Overall Market Size
2.1 Global Recombinant Hepatitis B Vaccine Market Size: 2022 VS 2030
2.2 Global Recombinant Hepatitis B Vaccine Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Recombinant Hepatitis B Vaccine Sales: 2018-2030
3 Company Landscape
3.1 Top Recombinant Hepatitis B Vaccine Players in Global Market
3.2 Top Global Recombinant Hepatitis B Vaccine Companies Ranked by Revenue
3.3 Global Recombinant Hepatitis B Vaccine Revenue by Companies
3.4 Global Recombinant Hepatitis B Vaccine Sales by Companies
3.5 Global Recombinant Hepatitis B Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Hepatitis B Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Hepatitis B Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Hepatitis B Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Hepatitis B Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Hepatitis B Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Hepatitis B Vaccine Market Size Markets, 2022 & 2030
4.1.2 10mcg/ml
4.1.3 10mcg/0.5ml
4.2 By Type - Global Recombinant Hepatitis B Vaccine Revenue & Forecasts
4.2.1 By Type - Global Recombinant Hepatitis B Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Hepatitis B Vaccine Revenue, 2024-2030
4.2.3 By Type - Global Recombinant Hepatitis B Vaccine Revenue Market Share, 2018-2030
4.3 By Type - Global Recombinant Hepatitis B Vaccine Sales & Forecasts
4.3.1 By Type - Global Recombinant Hepatitis B Vaccine Sales, 2018-2023
4.3.2 By Type - Global Recombinant Hepatitis B Vaccine Sales, 2024-2030
4.3.3 By Type - Global Recombinant Hepatitis B Vaccine Sales Market Share, 2018-2030
4.4 By Type - Global Recombinant Hepatitis B Vaccine Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Hepatitis B Vaccine Market Size, 2022 & 2030
5.1.2 Newborn
5.1.3 Primary School Students
5.1.4 Adult
5.2 By Application - Global Recombinant Hepatitis B Vaccine Revenue & Forecasts
5.2.1 By Application - Global Recombinant Hepatitis B Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Hepatitis B Vaccine Revenue, 2024-2030
5.2.3 By Application - Global Recombinant Hepatitis B Vaccine Revenue Market Share, 2018-2030
5.3 By Application - Global Recombinant Hepatitis B Vaccine Sales & Forecasts
5.3.1 By Application - Global Recombinant Hepatitis B Vaccine Sales, 2018-2023
5.3.2 By Application - Global Recombinant Hepatitis B Vaccine Sales, 2024-2030
5.3.3 By Application - Global Recombinant Hepatitis B Vaccine Sales Market Share, 2018-2030
5.4 By Application - Global Recombinant Hepatitis B Vaccine Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Recombinant Hepatitis B Vaccine Market Size, 2022 & 2030
6.2 By Region - Global Recombinant Hepatitis B Vaccine Revenue & Forecasts
6.2.1 By Region - Global Recombinant Hepatitis B Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Hepatitis B Vaccine Revenue, 2024-2030
6.2.3 By Region - Global Recombinant Hepatitis B Vaccine Revenue Market Share, 2018-2030
6.3 By Region - Global Recombinant Hepatitis B Vaccine Sales & Forecasts
6.3.1 By Region - Global Recombinant Hepatitis B Vaccine Sales, 2018-2023
6.3.2 By Region - Global Recombinant Hepatitis B Vaccine Sales, 2024-2030
6.3.3 By Region - Global Recombinant Hepatitis B Vaccine Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Recombinant Hepatitis B Vaccine Revenue, 2018-2030
6.4.2 By Country - North America Recombinant Hepatitis B Vaccine Sales, 2018-2030
6.4.3 US Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.4.4 Canada Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.4.5 Mexico Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Recombinant Hepatitis B Vaccine Revenue, 2018-2030
6.5.2 By Country - Europe Recombinant Hepatitis B Vaccine Sales, 2018-2030
6.5.3 Germany Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.5.4 France Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.5.5 U.K. Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.5.6 Italy Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.5.7 Russia Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.5.8 Nordic Countries Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.5.9 Benelux Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Recombinant Hepatitis B Vaccine Revenue, 2018-2030
6.6.2 By Region - Asia Recombinant Hepatitis B Vaccine Sales, 2018-2030
6.6.3 China Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.6.4 Japan Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.6.5 South Korea Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.6.6 Southeast Asia Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.6.7 India Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Recombinant Hepatitis B Vaccine Revenue, 2018-2030
6.7.2 By Country - South America Recombinant Hepatitis B Vaccine Sales, 2018-2030
6.7.3 Brazil Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.7.4 Argentina Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Hepatitis B Vaccine Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Recombinant Hepatitis B Vaccine Sales, 2018-2030
6.8.3 Turkey Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.8.4 Israel Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.8.5 Saudi Arabia Recombinant Hepatitis B Vaccine Market Size, 2018-2030
6.8.6 UAE Recombinant Hepatitis B Vaccine Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Recombinant Hepatitis B Vaccine Major Product Offerings
7.1.4 Merck Recombinant Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 GlaxoSmithKline Plc
7.2.1 GlaxoSmithKline Plc Company Summary
7.2.2 GlaxoSmithKline Plc Business Overview
7.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Major Product Offerings
7.2.4 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 GlaxoSmithKline Plc Key News & Latest Developments
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Company Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Major Product Offerings
7.3.4 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Inc. Key News & Latest Developments
7.4 Sanofi Pasteur
7.4.1 Sanofi Pasteur Company Summary
7.4.2 Sanofi Pasteur Business Overview
7.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Major Product Offerings
7.4.4 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Pasteur Key News & Latest Developments
7.5 CSL Limited
7.5.1 CSL Limited Company Summary
7.5.2 CSL Limited Business Overview
7.5.3 CSL Limited Recombinant Hepatitis B Vaccine Major Product Offerings
7.5.4 CSL Limited Recombinant Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 CSL Limited Key News & Latest Developments
7.6 Emergent Biosolutions
7.6.1 Emergent Biosolutions Company Summary
7.6.2 Emergent Biosolutions Business Overview
7.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Major Product Offerings
7.6.4 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Emergent Biosolutions Key News & Latest Developments
7.7 Serum Institute of India
7.7.1 Serum Institute of India Company Summary
7.7.2 Serum Institute of India Business Overview
7.7.3 Serum Institute of India Recombinant Hepatitis B Vaccine Major Product Offerings
7.7.4 Serum Institute of India Recombinant Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Serum Institute of India Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Major Product Offerings
7.8.4 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 Hualan Biological Engineering
7.9.1 Hualan Biological Engineering Company Summary
7.9.2 Hualan Biological Engineering Business Overview
7.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Major Product Offerings
7.9.4 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Hualan Biological Engineering Key News & Latest Developments
7.10 NCPC
7.10.1 NCPC Company Summary
7.10.2 NCPC Business Overview
7.10.3 NCPC Recombinant Hepatitis B Vaccine Major Product Offerings
7.10.4 NCPC Recombinant Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 NCPC Key News & Latest Developments
7.11 China National Biotec Group
7.11.1 China National Biotec Group Company Summary
7.11.2 China National Biotec Group Recombinant Hepatitis B Vaccine Business Overview
7.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Major Product Offerings
7.11.4 China National Biotec Group Recombinant Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 China National Biotec Group Key News & Latest Developments
7.12 Dalian Hissen Bio-pharm
7.12.1 Dalian Hissen Bio-pharm Company Summary
7.12.2 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Business Overview
7.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Major Product Offerings
7.12.4 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Dalian Hissen Bio-pharm Key News & Latest Developments
7.13 Beijing Tiantan Biological
7.13.1 Beijing Tiantan Biological Company Summary
7.13.2 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Business Overview
7.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Major Product Offerings
7.13.4 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Beijing Tiantan Biological Key News & Latest Developments
8 Global Recombinant Hepatitis B Vaccine Production Capacity, Analysis
8.1 Global Recombinant Hepatitis B Vaccine Production Capacity, 2018-2030
8.2 Recombinant Hepatitis B Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Hepatitis B Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Hepatitis B Vaccine Supply Chain Analysis
10.1 Recombinant Hepatitis B Vaccine Industry Value Chain
10.2 Recombinant Hepatitis B Vaccine Upstream Market
10.3 Recombinant Hepatitis B Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Hepatitis B Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Recombinant Hepatitis B Vaccine in Global Market
Table 2. Top Recombinant Hepatitis B Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Recombinant Hepatitis B Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Recombinant Hepatitis B Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Recombinant Hepatitis B Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Recombinant Hepatitis B Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Recombinant Hepatitis B Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Recombinant Hepatitis B Vaccine Product Type
Table 9. List of Global Tier 1 Recombinant Hepatitis B Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Hepatitis B Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Recombinant Hepatitis B Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Recombinant Hepatitis B Vaccine Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Recombinant Hepatitis B Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Recombinant Hepatitis B Vaccine Sales (K Units), 2024-2030
Table 16. By Application ? Global Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Recombinant Hepatitis B Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Recombinant Hepatitis B Vaccine Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Recombinant Hepatitis B Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Recombinant Hepatitis B Vaccine Sales (K Units), 2024-2030
Table 21. By Region ? Global Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Recombinant Hepatitis B Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Recombinant Hepatitis B Vaccine Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Recombinant Hepatitis B Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Recombinant Hepatitis B Vaccine Sales (K Units), 2024-2030
Table 26. By Country - North America Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Recombinant Hepatitis B Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Recombinant Hepatitis B Vaccine Sales, (K Units), 2024-2030
Table 30. By Country - Europe Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Recombinant Hepatitis B Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Recombinant Hepatitis B Vaccine Sales, (K Units), 2024-2030
Table 34. By Region - Asia Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Recombinant Hepatitis B Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Recombinant Hepatitis B Vaccine Sales, (K Units), 2024-2030
Table 38. By Country - South America Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Recombinant Hepatitis B Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Recombinant Hepatitis B Vaccine Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Recombinant Hepatitis B Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Recombinant Hepatitis B Vaccine Sales, (K Units), 2024-2030
Table 46. Merck Company Summary
Table 47. Merck Recombinant Hepatitis B Vaccine Product Offerings
Table 48. Merck Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. GlaxoSmithKline Plc Company Summary
Table 51. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Offerings
Table 52. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. GlaxoSmithKline Plc Key News & Latest Developments
Table 54. Pfizer Inc. Company Summary
Table 55. Pfizer Inc. Recombinant Hepatitis B Vaccine Product Offerings
Table 56. Pfizer Inc. Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Pfizer Inc. Key News & Latest Developments
Table 58. Sanofi Pasteur Company Summary
Table 59. Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Offerings
Table 60. Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Sanofi Pasteur Key News & Latest Developments
Table 62. CSL Limited Company Summary
Table 63. CSL Limited Recombinant Hepatitis B Vaccine Product Offerings
Table 64. CSL Limited Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. CSL Limited Key News & Latest Developments
Table 66. Emergent Biosolutions Company Summary
Table 67. Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Offerings
Table 68. Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Emergent Biosolutions Key News & Latest Developments
Table 70. Serum Institute of India Company Summary
Table 71. Serum Institute of India Recombinant Hepatitis B Vaccine Product Offerings
Table 72. Serum Institute of India Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Serum Institute of India Key News & Latest Developments
Table 74. Johnson & Johnson Company Summary
Table 75. Johnson & Johnson Recombinant Hepatitis B Vaccine Product Offerings
Table 76. Johnson & Johnson Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Johnson & Johnson Key News & Latest Developments
Table 78. Hualan Biological Engineering Company Summary
Table 79. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Offerings
Table 80. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Hualan Biological Engineering Key News & Latest Developments
Table 82. NCPC Company Summary
Table 83. NCPC Recombinant Hepatitis B Vaccine Product Offerings
Table 84. NCPC Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. NCPC Key News & Latest Developments
Table 86. China National Biotec Group Company Summary
Table 87. China National Biotec Group Recombinant Hepatitis B Vaccine Product Offerings
Table 88. China National Biotec Group Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. China National Biotec Group Key News & Latest Developments
Table 90. Dalian Hissen Bio-pharm Company Summary
Table 91. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Offerings
Table 92. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Dalian Hissen Bio-pharm Key News & Latest Developments
Table 94. Beijing Tiantan Biological Company Summary
Table 95. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Offerings
Table 96. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Beijing Tiantan Biological Key News & Latest Developments
Table 98. Recombinant Hepatitis B Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Recombinant Hepatitis B Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Recombinant Hepatitis B Vaccine Production by Region, 2018-2023 (K Units)
Table 101. Global Recombinant Hepatitis B Vaccine Production by Region, 2024-2030 (K Units)
Table 102. Recombinant Hepatitis B Vaccine Market Opportunities & Trends in Global Market
Table 103. Recombinant Hepatitis B Vaccine Market Drivers in Global Market
Table 104. Recombinant Hepatitis B Vaccine Market Restraints in Global Market
Table 105. Recombinant Hepatitis B Vaccine Raw Materials
Table 106. Recombinant Hepatitis B Vaccine Raw Materials Suppliers in Global Market
Table 107. Typical Recombinant Hepatitis B Vaccine Downstream
Table 108. Recombinant Hepatitis B Vaccine Downstream Clients in Global Market
Table 109. Recombinant Hepatitis B Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Hepatitis B Vaccine Segment by Type in 2022
Figure 2. Recombinant Hepatitis B Vaccine Segment by Application in 2022
Figure 3. Global Recombinant Hepatitis B Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Hepatitis B Vaccine Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Recombinant Hepatitis B Vaccine Revenue, 2018-2030 (US$, Mn)
Figure 7. Recombinant Hepatitis B Vaccine Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Hepatitis B Vaccine Revenue in 2022
Figure 9. By Type - Global Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Recombinant Hepatitis B Vaccine Revenue Market Share, 2018-2030
Figure 11. By Type - Global Recombinant Hepatitis B Vaccine Sales Market Share, 2018-2030
Figure 12. By Type - Global Recombinant Hepatitis B Vaccine Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Recombinant Hepatitis B Vaccine Revenue Market Share, 2018-2030
Figure 15. By Application - Global Recombinant Hepatitis B Vaccine Sales Market Share, 2018-2030
Figure 16. By Application - Global Recombinant Hepatitis B Vaccine Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Recombinant Hepatitis B Vaccine Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Recombinant Hepatitis B Vaccine Revenue Market Share, 2018-2030
Figure 20. By Region - Global Recombinant Hepatitis B Vaccine Sales Market Share, 2018-2030
Figure 21. By Country - North America Recombinant Hepatitis B Vaccine Revenue Market Share, 2018-2030
Figure 22. By Country - North America Recombinant Hepatitis B Vaccine Sales Market Share, 2018-2030
Figure 23. US Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Recombinant Hepatitis B Vaccine Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Recombinant Hepatitis B Vaccine Sales Market Share, 2018-2030
Figure 28. Germany Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 29. France Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Recombinant Hepatitis B Vaccine Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Recombinant Hepatitis B Vaccine Sales Market Share, 2018-2030
Figure 37. China Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 41. India Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Recombinant Hepatitis B Vaccine Revenue Market Share, 2018-2030
Figure 43. By Country - South America Recombinant Hepatitis B Vaccine Sales Market Share, 2018-2030
Figure 44. Brazil Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Recombinant Hepatitis B Vaccine Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share, 2018-2030
Figure 48. Turkey Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Recombinant Hepatitis B Vaccine Revenue, (US$, Mn), 2018-2030
Figure 52. Global Recombinant Hepatitis B Vaccine Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Recombinant Hepatitis B Vaccine by Region, 2022 VS 2030
Figure 54. Recombinant Hepatitis B Vaccine Industry Value Chain
Figure 55. Marketing Channels
